BSECompany Update13 Aug 2026 · 13 Aug 2026, 11:30 am
Monitoring Agency Report for the quarter ended June 30, 2026 on the utilisation of proceeds raised though issuance of Equity Shares by way of public issue.
Emmvee Photovoltaic Power Ltd · 544608
✦ AI SummaryResults
Emmvee Photovoltaic Power Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of proceeds raised through its public issue of equity shares.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Emmvee Photovoltaic Power Ltd - 544608 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
99d47874-a34c-49f9-99b1-03d92c8c2156.pdf
View document text
Date: August 13, 2026
BSE Limited National Stock Exchange of India Limited
BSE Scrip Code: 544608 NSE Scrip Symbol: EMMVEE
Dear Sir/Ma’am,
Sub: Submission of Monitoring Agency Report for the quarter ended June 30, 2026
Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find enclosed the Monitoring Agency Report for the quarter ended June 30,
2026 issued by CARE Ratings Limited in respect of utilisation of funds raised through public Issue of
equity shares made by the Company.
This intimation along with the Monitoring Agency Report is also being uploaded on the Company’s
website: https://www.emmveepv.com/Investors/
This is for your kind information and dissemination.
Thanking You,
For and on behalf of Emmvee Photovoltaic Power Limited
(Formerly known as Emmvee Photovoltaic Power Private Limited)
Pawan Kumar Jain
Chief Financial Officer
No. CARE/NRO/GEN/2026-27/1091
The Board of Directors
Emmvee Photovoltaic Power Limited
13/1, International Airport Road, Bettahalasur
Post, Bengaluru, Karnataka-562157
08/11/2026
Monitoring Agency Report for the quarter ended 06/30/2026-in relation to the IPO of Emmvee Photovoltaic
Power Limited (
We write in our capacity of Monitoring Agency for the IPOfor the amount aggregating to Rs. 2143.86crore of the
Company and refer to our duties cast under Regulation 41of the Securities & Exchange Board of India (Issue of
Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended 06/30/2026 as per
aforesaid SEBI Regulations and Monitoring Agency Agreement dated 10/29/2025.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Saurabh Singhal
Associate Director
Saurabh.Singhal@careedge.in
CARE Ratings Limited
9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital
Noida, Road, Off Eastern Express Highway, Sion (East),
Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai -400 022
Phone: +91-120-4452000 Phone: +91-22-6754 3456
Email:
Report of the Monitoring Agency
Name of the issuer: Emmvee Photovoltaic Power Limited
For quarter ended: 06/30/2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: NIL
(b) Range of Deviation:Not Applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the
objects of the issue based on the information provided by the Issuer and information obtained from sources
believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent
verification of any information/ certifications/ statements it receives. This Report is not intended to create any
legally binding obligations on the MA which accepts no responsibility, whatsoever for loss or damage from the use
of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any
security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be
construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user
of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies
Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm
that there is no conflict ofinterest in such relationship/interest while monitoring and reporting the utilization of the
issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where
s Management / Audit Committee of the Board of Directors subsequent to the MA
submitting their report to the issuer and before dissemination of the report through stock exchanges. These
sections have not been reviewed by the MA, and the MA takes no respons
Management/Board.
Signature:
Name and designation of the Authorized Signatory: Saurabh Singhal
Designation of Authorized person/Signing Authority: Associate Director
CARE Ratings Limited
9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital
Noida, Road, Off Eastern Express Highway, Sion (East),
Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai -400 022
Phone: +91-120-4452000 Phone: +91-22-6754 3456
Email:
Disclaimers to MA report:
a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as ). The
MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the
information provided by the Issuer and information obtained from sources believed by it to be accurate
and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any
security of the Issuer in any manner whatsoever.
b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to
inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by
the management /officials/ consultants of the Issuer and third-party sources like statutory auditor/internal
auditor which is peer reviewed audit firmappointed by the Issuer believed by it to be accurate and reliable.
c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the
MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information.
The MA is also not responsible for any errors in transmission and specifically states that it, or its directors,
employees do not have any financial liabilities whatsoever to the users of this Report.
d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to
the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information
from sources it believes to be reliable, it does not perform an audit and undertakes no independent
verification of any information/ certifications/ statements it receives from statutory auditors/internal
auditor which is peer reviewed audit firm, lawyers, chartered engineers or other experts, and relies on in
its reports.
e) The MA or its affiliates may have other commercial transactions with the entity to which the report
pertains. As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed
to be issued by the issuer that is subject matter of this report. The MA may receive separate compensation
for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments,
facilities, securities or from obligors.
CARE Ratings Limited
9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital
Noida, Road, Off Eastern Express Highway, Sion (East),
Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai -400 022
Phone: +91-120-4452000 Phone: +91-22-6754 3456
Email: